Multi-omics analysis of epigenetic dysregulation reveals clinical heterogeneity and evaluates the immunotherapeutic potential of lung adenocarcinoma
Saved in:
| Main Authors: | Yuqing Ren, Zaoqu Liu, Yi Yue, Siyuan Weng, Hongxia Jia, Jing Li, Ping Li, Chunya Lu, Xinwei Han, Guojun Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-09-01
|
| Series: | Genes and Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304225000509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
eQTL and multi-omics integration reveal PPIH as a prognostic and immunotherapeutic biomarker
by: Fenglin Lv, et al.
Published: (2025-08-01) -
Multi-Omics Perspectives on Testicular Aging: Unraveling Germline Dysregulation, Niche Dysfunction, and Epigenetic Remodeling
by: Aris Kaltsas
Published: (2025-06-01) -
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction
by: Ning Wang, et al.
Published: (2025-02-01) -
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
by: Dan Shan, et al.
Published: (2025-05-01) -
Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer
by: Xinyi Zhang, et al.
Published: (2025-06-01)